Meta-Analysis of the Relationship Between Non–High-Density Lipoprotein Cholesterol Reduction and Coronary Heart Disease Risk

Cited by (365)

Items 101–200 of 365

1. Management of Dyslipidemia as a Cardiovascular Risk Factor in Individuals With Nonalcoholic Fatty Liver Disease
   Kathleen E. Corey, Naga Chalasani · 2013 · Clinical Gastroenterology and Hepatology
2. Nonalcoholic steatohepatitis is associated with an atherogenic lipoprotein subfraction profile
   Kathleen E. Corey, Joseph Misdraji, Louis G. Gelrud, Hui Zheng, Raymond T. Chung, Ronald M. Krauss · 2014 · Lipids in Health and Disease
3. A diet rich in oat bran improves blood lipids and hemostatic factors, and reduces apparent energy digestibility in young healthy volunteers
   Mette Kristensen, Susanne Bügel · 2011 · European Journal of Clinical Nutrition
4. Non–High-Density Lipoprotein Cholesterol as a Biomarker for Nonalcoholic Steatohepatitis
   Kathleen E. Corey, Michelle Lai, Louis G. Gelrud, Joseph Misdraji, Lydia L. Barlow, Hui Zheng, Karin L. Andersson, Michael Thiim, Daniel Stephan Pratt, Raymond T. Chung · 2012 · Clinical Gastroenterology and Hepatology
5. Risk stratification in cardiovascular disease primary prevention – scoring systems, novel markers, and imaging techniques
   Faiez M. Zannad, Guy De Backer, Ian M Graham, Matthias Lorenz, Giuseppe Mancia, David A. Morrow, Željko Reiner, Wolfgang Köenig, Jean Dallongeville, Robert J. MacFadyen et al. · 2012 · Fundamental and Clinical Pharmacology
6. Mipomersen is a promising therapy in the management of hypercholesterolemia: a meta-analysis of randomized controlled trials
   Li, Na, Li, Qing, Tian, Xia-Qiu, Qian, Hai-Yan, Yang, Yue-Jin · 2014 · American Journal of Cardiovascular Drugs
7. Recent advances in cardiovascular disease research driven by metabolomics technologies in the context of systems biology
   Boyao Zhang, Thierry Schmidlin · 2024 · npj Metabolic Health and Disease
8. Triglyceride and cardiovascular risk: A critical appraisal
   Awadhesh Kumar Singh, Ritu Singh · 2016 · Indian Journal of Endocrinology and Metabolism
9. A Summary and Critical Assessment of the 2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Disease Risk in Adults: Filling the Gaps
   Francisco Alejandro López-Jiménez, Vinaya Simha, Randal J. Thomas, Thomas G. Allison, Ananda Basu, Regis Fernandes, R. Todd Hurst, Stephen Louis Kopecky, Iftikhar J. Kullo, Sharon L. Mulvagh et al. · 2014 · Mayo Clinic Proceedings
10. Effects of soy protein on lipoprotein lipids and fecal bile acid excretion in men and women with moderate hypercholesterolemia
    Kevin Carl Maki, Dustie N. Butteiger, Tia M. Rains, Andrea L. Lawless, Matthew S. Reeves, Chuck Schasteen, Elaine Susan Krul · 2010 · Journal of clinical lipidology
11. Are You Targeting Non–High-Density Lipoprotein Cholesterol?
    Jennifer G. Robinson · 2009 · Journal of the American College of Cardiology
12. Impact of Baseline Lipoprotein and C-Reactive Protein Levels on Coronary Atheroma Regression Following High-Intensity Statin Therapy
    Rishi Puri, Steven E. Nissen, Mingyuan Shao, Kiyoko Uno, Yu Kataoka, Samir Ramesh Kapadia, Emin Murat Tuzcu, Stephen James Nicholls · 2014 · The American Journal of Cardiology
13. Modifiable cardiovascular risk factors in adults aged 40–79 years in Germany with and without prior coronary heart disease or stroke
    Julia Truthmann, Markus Alexander Busch, Christa Scheidt‐Nave, Gert Mensink, Antje Gößwald, Matthias Endres, Hannelore K. Neuhauser · 2015 · BMC Public Health
14. Global prevalence of dyslipidaemia in adult populations: a systematic review protocol
    Mohamed-Syarif Mohamed-Yassin, Noorhida Baharudin, Suraya Abdul-Razak, Anis Safura Ramli, Nai Ming Lai · 2021 · BMJ Open
15. 2016 ESC/EAS Guidelines for the Management of Dyslipidaemias
    Alberico Luigi Catapano, Ian M Graham, Guy De Backer, Olov Wiklund, M. John Chapman, Heinz Drexel, Arno Wilhelmus Hoes, Catriona Sian Jennings, Ulf Landmesser, Terje Rolf Pedersen et al. · 2016 · Kardiologia Polska
16. How well can we control dyslipidemias through lifestyle modifications?
    Riccardi, Gabriele, Vaccaro, Olga, Costabile, Giuseppina, Rivellese, Angela A. · 2016 · Current Cardiology Reports
17. Treating mixed hyperlipidemia and the atherogenic lipid phenotype for prevention of cardiovascular events
    Rubenfire, Melvyn, Brook, Robert D., Rosenson, Robert S. · 2010 · The American Journal of Medicine
18. How to assess and manage cardiovascular risk associated with lipid alterations beyond LDL
    Maurizio Rocco Averna, Erik S.G. Stroes, Masatsune Ogura, Arman Postadzhiyan, Miha Čerček, Paolo Calabrò, Patrizia Suppressa · 2017 · Atherosclerosis Supplements
19. ApoB in clinical care: Pro and Con
    Allan D. Sniderman, Jennifer G. Robinson · 2018 · Atherosclerosis
20. Triglyceride/low-density-lipoprotein cholesterol ratio is the most valuable predictor for increased small, dense LDL in type 2 diabetes patients
    Gen Ouchi, Ichiro Komiya, Shinichiro Taira, Tamio Wakugami, Yusuke Ohya · 2022 · Lipids in Health and Disease
21. A comparison of non-HDL and LDL cholesterol goal attainment in a large, multinational patient population: The Lipid Treatment Assessment Project 2
    Santos, Raul D., Waters, David D., Tarasenko, Lisa, Messig, Michael, Jukema, J. Wouter, Chiang, Cheng-Wen, Ferrieres, Jean, Foody, JoAnne M. · 2012 · Atherosclerosis
22. Contemporary Management of Stable Coronary Artery Disease
    Dario Tino Bertolone, Emanuele Gallinoro, Giuseppe Esposito, Pasquale Paolisso, Konstantinos Bermpeis, Cristina De Colle, Davide Fabbricatore, Niya Boykova Mileva, Chiara Valeriano, Daniel Munhoz et al. · 2022 · High Blood Pressure & Cardiovascular Prevention
23. Improvement in Liver Histology Is Associated With Reduction in Dyslipidemia in Children With Nonalcoholic Fatty Liver Disease
    Kathleen E. Corey, Raj Vuppalanchi, Miriam B. Vos, Rohit Kohli, Jean Pappas Molleston, Laura Wilson, Aynur Ünalp–Arida, Oscar W. Cummings, Joel E. Lavine, Naga Chalasani · 2014 · Journal of Pediatric Gastroenterology and Nutrition
24. Chinese expert consensus on blood lipid management in patients with diabetes (2024 edition)
    Yang Xiao, Bilian Yu, Chao Chen, Shuai Wang, Die Hu, Chao Wu, Yonghong Luo, Lingxiang Xie, Chenyu Li, Daoquan Peng et al. · 2024 · Journal of Translational Internal Medicine
25. Lipid-altering effects of a dietary supplement tablet containing free plant sterols and stanols in men and women with primary hypercholesterolaemia: a randomized, placebo-controlled crossover trial
    Kevin Carl Maki, Andrea L. Lawless, Matthew S. Reeves, Mary R. Dicklin, Belinda H. Jenks, Ed Shneyvas, James R. Brooks · 2011 · International Journal of Food Sciences and Nutrition
26. Statins, fibrates, nicotinic acid, cholesterol absorption inhibitors, anion‐exchange resins, omega‐3 fatty acids: which drugs for which patients?
    Heinz Drexel · 2009 · Fundamental and Clinical Pharmacology
27. Anabolic Steroid Use and Longitudinal, Radial, and Circumferential Cardiac Motion
    Peter J. Angell, Neil J. Chester, DANIEL JOHN GREEN, REHAAN SHAH, John D. Somauroo, Greg Whyte, Keith George · 2011 · Medicine & Science in Sports & Exercise
28. The Benefits and Risks of Statin Therapy in Ischemic Stroke: A Review of the Literature
    Shui‐Ping Zhao, Zhao Wang, Zhi-Jie Xiao · 2019 · Neurology India
29. Cholesterol-lowering activity of protocatechuic acid is mediated by increasing the excretion of bile acids and modulating gut microbiota and producing short-chain fatty acids
    Yimin Zhao, Zouyan He, Wangjun Hao, Hanyue Zhu, Jianhui Liu, Ka Ying Ma, Wen‐Sen He, Zhen‐Yu Chen · 2021 · Food & Function
30. Relationship between Coronary Artery Disease and Non-HDL-C, and Effect of Highly Purified EPA on the Risk of Coronary Artery Disease in Hypercholesterolemic Patients Treated with Statins: Sub-Analysis of the Japan EPA Lipid Intervention Study (JELIS)
    Sasaki, Jun, Yokoyama, Mitsuhiro, Matsuzaki, Masunori, Saito, Yasushi, Origasa, Hideki, Ishikawa, Yuichi, Oikawa, Shinichi, Itakura, Hiroshige, Hishida, Hitoshi, Kita, Toru et al. · 2012 · Journal of Atherosclerosis and Thrombosis
31. The Role of Triglyceride-rich Lipoproteins and Their Remnants in Atherosclerotic Cardiovascular Disease
    Mohanad H. Gabani, Michael David Shapiro, Peter Paul Toth · 2023 · European Cardiology Review
32. Benefits & risks of statin therapy for primary prevention of cardiovascular disease in Asian Indians - a population with the highest risk of premature coronary artery disease & diabetes.
    Enas A Enas, Arun Thekkekarott Kuruvila, Pravien Khanna, C. S. Pitchumoni, Viswanathan Mohan · 2013 · Europe PMC (PubMed Central)
33. Prevention of High-Fat Diet-Induced Hypercholesterolemia by Lactobacillus reuteri Fn041 Through Promoting Cholesterol and Bile Salt Excretion and Intestinal Mucosal Barrier Functions
    Mengyao Lu, Jin Sun, Yuning Zhao, Haowen Zhang, Xinyue Li, Jingbo Zhou, Hongyang Dang, Jidong Zhang, Wenjing Huang, Ce Qi et al. · 2022 · Frontiers in Nutrition
34. Efficacy, effectiveness and real life goal attainment of statins in managing cardiovascular risk
    Charles J. Glueck, Naila Goldenberg · 2009 · Vascular Health and Risk Management
35. Effect of Ezetimibe on LDL-C Lowering and Atherogenic Lipoprotein Profiles in Type 2 Diabetic Patients Poorly Controlled by Statins
    Kentaro Sakamoto, Mitsunobu Kawamura, Takahide Kohro, Masao Omura, Takayuki Watanabe, Keiko Ashidate, Toshiyuki Horiuchi, Hidehiko Hara, Nobuo Sekine, Rina Chin et al. · 2015 · PLoS ONE
36. Approach to Statin Use in 2016: an Update
    P. Elliott Miller, Seth Shay Martin · 2016 · Current Atherosclerosis Reports
37. Effects on lipid profile of supplementation with vitamin D in type 2 diabetic patients with vitamin D deficiency
    José Manuel Ramiro-Lozano, José María Calvo‐Romero · 2015 · Therapeutic Advances in Endocrinology and Metabolism
38. Non-HDL cholesterol goal attainment and its relationship with triglyceride concentrations among diabetic subjects with cardiovascular disease: a nationwide survey of 2674 individuals in Hungary
    Mark, Laszlo, Vallejo-Vaz, Antonio J., Reiber, Istvan, Paragh, György, Kondapally Seshasai, Sreenivasa Rao, Ray, Kausik K. · 2015 · Atherosclerosis
39. Impact of omega-3 fatty acids and/or plant sterol supplementation on non-HDL cholesterol levels of dyslipidemic Indian adults
    Shweta Khandelwal, Rahul R Shidhaye, Isabelle Demonty, Lakshmy Ramakrishnan, Ruby Gupta, Dorairaj Prabhakaran, Srinath Reddy · 2012 · Journal of Functional Foods
40. Administration of highly purified eicosapentaenoic acid to statin-treated diabetic patients further improves vascular function
    Junko Sasaki, Takashi Miwa, Masato Odawara · 2012 · Endocrine Journal
41. Focus on Therapeutic Strategies of Nonalcoholic Fatty Liver Disease
    Marilena Durazzo, Paola Belci, Alessandro Collo, Enrica Grisoglio, Simona Bo · 2012 · International Journal of Hepatology
42. High prevalence of dyslipidaemia subtypes and their associated personal and clinical attributes in Malaysian adults: the REDISCOVER study
    Mohamed-Syarif Mohamed-Yassin, Noorhida Baharudin, Aqil Mohammad Daher, Najmin Abu Bakar, Anis Safura Ramli, Suraya Abdul-Razak, Nor Ashikin Mohamed Noor Khan, Mariam Mohamad, Khalid Yusoff · 2021 · BMC Cardiovascular Disorders
43. Non‐HDL cholesterol vs. Apo B for risk of coronary heart disease in healthy individuals: the EPIC‐Norfolk prospective population study
    Sondermeijer, Brigitte M., Rana, Jamal S., Arsenault, Benoit J., Shah, Prediman K., Kastelein, John J.P., Wareham, Nicholas J., Boekholdt, S. Matthijs, Khaw, Kay‐Tee · 2013 · European Journal of Clinical Investigation
44. Dyslipidemia Intervention in Metabolic Syndrome: Emphasis on Improving Lipids and Clinical Event Reduction
    Carl J. Lavie, Richard V. Milani, James Henry O’Keefe · 2011 · The American Journal of the Medical Sciences
45. Strategies for vascular disease prevention: The role of lipids and related markers including apolipoproteins, low-density lipoproteins (LDL)-particle size, high sensitivity C-reactive protein (hs-CRP), lipoprotein-associated phospholipase A2 (Lp-PLA2) and lipoprotein(a) (Lp(a))
    Dhayana Dallmeier, Wolfgang Köenig · 2014 · Best Practice & Research Clinical Endocrinology & Metabolism
46. Diagnostic et traitement des hypercholestérolémies familiales (HF) chez l’adulte : recommandations de la Nouvelle société française d’athérosclérose (NSFA)
    Michel Farnier, Éric Bruckert, Cathérine Boileau, Michel Krempf · 2013 · La Presse Médicale
47. Apolipoprotein B/apolipoprotein A1 ratio and non-high-density lipoprotein cholesterol
    P. Liting, Guoping Lü, C. Zhenyue · 2014 · Herz
48. Food prices and blood cholesterol
    Ilya M. Rahkovsky, Christian Gregory · 2012 · Economics & Human Biology
49. Nibbling versus feasting: which meal pattern is better for heart disease prevention?
    Surabhi Bhutani, Krista A Varady · 2009 · Nutrition Reviews
50. Triglycerides revisited: is hypertriglyceridaemia a necessary therapeutic target in cardiovascular disease?
    Heinz Drexel, Juan Luis Tamargo, Juan Carlos Kaski, Basil S. Lewis, Christoph H. Saely, Peter Fraunberger, Dobromir Dobrev, Maki Komiyama, THOMAS PLATTNER, Stefan Agewall et al. · 2023 · European Heart Journal - Cardiovascular Pharmacotherapy
51. Cowpea protein reduces LDL-cholesterol and apolipoprotein B concentrations, but does not improve biomarkers of inflammation or endothelial dysfunction in adults with moderate hypercholesterolemia.
    Karoline de Macêdo Gonçalves Frota, Raul Dias dos Santos Filho, V. Q. Ribeiro, José Alfredo Gomes Arêas · 2015 · PubMed
52. Meta-analysis of serum non-high-density lipoprotein cholesterol and risk of coronary heart disease in the general population
    Hongtao Liu, Xia Deng, Yudong Peng, Qiutang Zeng, Zongren Song, Wenping He, Le Zhang, Gan Gao, Ting Xiao, Xuedong Yu · 2017 · Clinica Chimica Acta
53. Supplementation of Bacillus sp. DU-106 reduces hypercholesterolemia and ameliorates gut dysbiosis in high-fat diet rats
    Jianzhao Huang, Nan Xiao, Yiying Sun, Shanshan Wu, Wenni Tian, Yujian Lai, Pan Li, Bing Du · 2020 · Applied Microbiology and Biotechnology
54. Comparative safety and efficacy of low- or moderate-intensity statin plus ezetimibe combination therapy and high-intensity statin monotherapy: A meta-analysis of randomized controlled studies
    Young‐Mi Ah, Minseob Jeong, Hye Duck Choi · 2022 · PLoS ONE
55. New Cholesterol Guidelines for the Management of Atherosclerotic Cardiovascular Disease Risk
    Bhavin B. Adhyaru, Terry A. Jacobson · 2016 · Endocrinology and Metabolism Clinics of North America
56. New Cholesterol Guidelines for the Management of Atherosclerotic Cardiovascular Disease Risk
    Bhavin B. Adhyaru, Terry A. Jacobson · 2015 · Cardiology Clinics
57. Current pharmacotherapeutic options for primary dyslipidemia in adults
    Arrigo F.G. Cicero, Matteo Landolfo, Fulvio Ventura, Claudio Borghi · 2019 · Expert Opinion on Pharmacotherapy
58. Association between sleep problems and multimorbidity patterns in older adults
    Stefany Cristina Claudino Idalino, Jaquelini Betta Canever, Letícia Martins Cândido, Kátia Jakovljevic Pudla Wagner, Bruno de Souza Moreira, Ana Lúcia Danielewicz, Núbia Carelli Pereira de Avelar · 2023 · BMC Public Health
59. Baseline Lipoprotein Lipids and Low-Density Lipoprotein Cholesterol Response to Prescription Omega-3 Acid Ethyl Ester Added to Simvastatin Therapy
    Kevin Carl Maki, Mary R. Dicklin, Michael H. Davidson, Ralph T. Doyle, Christie Mitchell Ballantyne · 2010 · The American Journal of Cardiology
60. Non-HDL Cholesterol and Evaluation of Cardiovascular Disease Risk.
    Katarzyna Bergmann · 2010 · PubMed Central
61. To B or Not to B: Is Non–High-Density Lipoprotein Cholesterol an Adequate Surrogate for Apolipoprotein B?
    Carl J. Lavie, Richard V. Milani, James Henry O’Keefe · 2010 · Mayo Clinic Proceedings
62. Achievement of specified low-density lipoprotein cholesterol, non-high-density lipoprotein cholesterol apolipoprotein B, and high-sensitivity C-reactive protein levels with ezetimibe/simvastatin or atorvastatin in metabolic syndrome patients with and without atherosclerotic vascular disease (from the VYMET study)
    Jennifer G. Robinson, Christie Mitchell Ballantyne, Willa A. Hsueh, Jeffrey Rosen, Jianxin Lin, Arvind Kumar Shah, Robert S. Lowe, Mary Elizabeth Hanson, Andrew M. Tershakovec · 2011 · Journal of clinical lipidology
63. High Doses of Rosuvastatin are Superior to Low Doses of Rosuvastatin Plus Fenofibrate or n‐3 Fatty Acids in Mixed Dyslipidemia
    Aris P. Agouridis, Vasilis Tsimihodimos, Theodosios D. Filippatos, Alexandros D. Tselepis, Moses Elisaf · 2011 · Lipids
64. Effects of Diet, Aerobic Exercise, or Both on Non-HDL-C in Adults: A Meta-Analysis of Randomized Controlled Trials
    George A. Kelley, Kristi Sharpe Kelley · 2012 · Cholesterol
65. Genetic Variants of the Fatty Acid Desaturase Gene Cluster Are Associated with Plasma LDL Cholesterol Levels in Japanese Males
    Yasuko Sone, Toshimi Kido, Tomomi Ainuki, Mariko Sonoda, Ikuyo Ichi, Satoru Kodama, Hirohito Sone, Kazuo N. Kondo, Yutaka Morita, Shigenobu Egawa et al. · 2013 · Journal of Nutritional Science and Vitaminology
66. Prevention of atherosclerosis with low-density lipoprotein cholesterol lowering—lipoprotein changes and interactions: the SANDS study
    Wm. James Howard, Marie Russell, Jerome L. Fleg, Mihriye Mete, Tauqeer Ali, Richard B. Devereux, James M. Galloway, James D. Otvos, Robert E. Ratner, Mary J. Roman et al. · 2009 · Journal of clinical lipidology
67. Consensus clinical recommendations for the management of plasma lipid disorders in the Middle East: 2021 update
    Nasreen Alsayed, Wael A. Almahmeed, Fahad Alnouri, Khalid Al-Waili, Hani Mohamed Sabbour, Kadhim Sulaiman, Mohammad Zubaid, Kausik Kumar Ray, Khalid Al‐Rasadi · 2021 · Atherosclerosis
68. The Role of Advanced Lipid Testing in the Prediction of Cardiovascular Disease
    Alvin Chandra, Anand K. Rohatgi · 2014 · Current Atherosclerosis Reports
69. Association between non‐high‐density lipoprotein cholesterol levels and asymptomatic vulnerable carotid atherosclerotic plaques
    J. Wu, J. Zhang, Anxin Wang, S. Chen, Shouling Wu, Xingquan Zhao · 2019 · European Journal of Neurology
70. Premature coronary heart disease and traditional risk factors-can we do better?
    Roxana Sadeghi, Nadia Adnani, Azam Erfanifar, Latif Gachkar, Zohreh Maghsoomi · 2013 · Europe PMC (PubMed Central)
71. Consensus clinical recommendations for the management of plasma lipid disorders in the Middle East
    Nasreen Sayed, Khalid Al Waili, Fatheya Alawadi, Saeed M G Al-Ghamdi, Wael A. Almahmeed, Fahad Alnouri, Mona Al Rukhaimi, Khalid Al‐Rasadi, Zuhier Ahmed Awan, Mohamed Farghaly et al. · 2016 · International Journal of Cardiology
72. Reduction of Some Atherogenic Indices in Patients with Non-Alcoholic Fatty Liver by Vitamin D and Calcium Co-Supplementation: A Double Blind Randomized Controlled Clinical Trial.
    Farzad Shidfar, Seyedeh Neda Mousavi, Hamid Lorvand Amiri, Shahram Agah, Sharieh Hoseini, Seyed Javad Hajimiresmaiel · 2019 · Europe PMC (PubMed Central)
73. Is directly measured low-density lipoprotein clinically equivalent to calculated low-density lipoprotein?
    Lawrence Baruch, Sanjay Agarwal, Bhanu P Gupta, Ann Frances Haynos, Swapna Johnson, Katelyn Kelly-Johnson, Calvin Eng · 2010 · Journal of clinical lipidology
74. Assessing Cardiovascular Risk and Testing in Type 2 Diabetes
    Anum Saeed, Christie Mitchell Ballantyne · 2017 · Current Cardiology Reports
75. Efficacy of Statin Therapy in Inducing Coronary Plaque Regression in Patients with Low Baseline Cholesterol Levels
    Kohei Wakabayashi, Tsuyoshi Nozue, Shingo Yamamoto, Shinichi Tohyama, Kazuki Fukui, Shigeo Umezawa, Yuko Onishi, Tomoyuki Kunishima, Akira Sato, Shogo Miyake et al. · 2016 · Journal of Atherosclerosis and Thrombosis
76. Which lipids should be analyzed for diagnostic workup and follow-up of patients with hyperlipidemias?
    Langlois, Michel R., Nordestgaard, Børge G. · 2018 · Current Cardiology Reports
77. Yi Mai granule improve energy supply of endothelial cells in atherosclerosis via miRNA-125a-5p regulating mitochondrial autophagy through Pink1-Mfn2-Parkin pathway
    De Zhao Kong, Peng Sun, Yi Lu, Ye Yang, Dong Yu Min, Si Cheng Zheng, Guan Lin Yang, Zhe Zhang, Guan Lin Yang, Jun Wen Jiang · 2023 · Journal of Ethnopharmacology
78. Does family history of metabolic syndrome affect the metabolic profile phenotype in young healthy individuals?
    Anna Lipińska, Magdalena Koczaj-Bremer, Krzysztof Jankowski, Agnieszka Kaźmierczak, Michał Ciurzyński, Aisha Ou-Pokrzewińska, Ewelina Mikocka, Zbigniew Lewandowski, Urszula Anna Demkow, Piotr Pruszczyk · 2014 · Diabetology & Metabolic Syndrome
79. High-Dose Simvastatin Exhibits Enhanced Lipid-Lowering Effects Relative to Simvastatin/Ezetimibe Combination Therapy
    Stuart G. Snowden, Dmitry Grapov, Magnus Settergren, F. L. D’Alexandri, Jesper Z. Haeggström, Oliver Fiehn, Tuulia Hyötyläinen, Theresa L. Pedersen, John W. I. Newman, Matej Orešič et al. · 2014 · Circulation Cardiovascular Genetics
80. ‘Trig-onometry’: non-high-density lipoprotein cholesterol as a therapeutic target in dyslipidaemia
    Terry A. Jacobson · 2010 · International Journal of Clinical Practice
81. Management of hyperlipidemia in pediatrics
    Stephen R. Daniels · 2012 · Current Opinion in Cardiology
82. Effects of ezetimibe, simvastatin and ezetimibe/simvastatin on correlations between apolipoprotein B, LDL cholesterol and non-HDL cholesterol in patients with primary hypercholesterolemia
    Michel Farnier, John R. Guyton, Erin H. Jensen, Adam B. Polis, Amy O. Johnson‐Levonas, Philippe Brudi · 2013 · Atherosclerosis
83. Intake of Saturated Fatty Acids Affects Atherogenic Blood Properties in Young, Caucasian, Overweight Women Even without Influencing Blood Cholesterol
    Jadwiga Hamułka, Dominika Głąbska, Dominika Guzek, Agnieszka B. Bialkowska, Agnieszka Sulich · 2018 · International Journal of Environmental Research and Public Health
84. Non-high-density lipoprotein cholesterol is a practical predictor of long-term cardiac death after coronary artery bypass grafting
    Yoshifumi Fukushima, Hirotoshi Ohmura, Hiroshi Mokuno, Kan Kajimoto, Takatoshi Kasai, Satoshi Hirayama, Katsumi Miyauchi, Takashi Miida, Atsushi Amano, Hiroyuki Daida · 2011 · Atherosclerosis
85. Non–high-density lipoprotein cholesterol reporting and goal attainment in primary care
    Salim S. Virani, Degang Wang, LeChauncy Woodard, Supicha S. Chitwood, Cassie R. Landrum, Franklin Joseph Zieve, Christie Mitchell Ballantyne, Laura A. Petersen · 2012 · Journal of clinical lipidology
86. Therapeutic Options to Further Lower C-Reactive Protein for Patients on Statin Treatment
    Parag H. Joshi, Terry A. Jacobson · 2010 · Current Atherosclerosis Reports
87. Non-HDL cholesterol is a better target for predicting periprocedural myocardial injury following percutaneous coronary intervention in type 2 diabetes
    Rui‐Xiang Zeng, Xiaolin Li, Minzhou Zhang, Yuan‐Lin Guo, Cheng‐Gang Zhu, Liheng Guo, Sha Li, Yan Zhang, Jian‐Jun Li · 2014 · Atherosclerosis
88. Using association rule mining to jointly detect clinical features and differentially expressed genes related to chronic inflammatory diseases
    Rosana Veroneze, Sâmia Cruz Tfaile Corbi, Bárbara Roque da Silva, Cristiane S. Rocha, Cláudia Vianna Maurer‐Morelli, Silvana Regina Perez Orrico, Joni Augusto Cirelli, Fernando José Von Zuben, Raquel Mantuaneli Scarel‐Caminaga · 2020 · PLoS ONE
89. Non–high-density lipoprotein cholesterol target achievement in patients on lipid-lowering drugs and stratified by triglyceride levels in the Arabian Gulf
    Khamis Al-Hashmi, Ibrahim S Al-Zakwani, Wael A. Almahmeed, Mohammed Arafah, Ali Talib Al-Hinai, Abdullah Mohammed Shehab, Omer Al Tamimi, Mahmoud Alawadhi, Shorook Al Herz, Faisal Al Anazi et al. · 2015 · Journal of clinical lipidology
90. Alirocumab Treatment and Achievement of Non‐High‐Density Lipoprotein Cholesterol and Apolipoprotein B Goals in Patients With Hypercholesterolemia: Pooled Results From 10 Phase 3 ODYSSEY Trials
    Harold Edward Bays, Lawrence A. Leiter, Helen Martina Colhoun, Desmond E. Thompson, Laurence Bessac, Robert C. Pordy, Peter Paul Toth · 2017 · Journal of the American Heart Association
91. Use of Plant Sterol and Stanol Fortified Foods in Clinical Practice
    Montserrat Cofán, Emilio Ros · 2018 · Current Medicinal Chemistry
92. Dyslipidemia
    G.B. John Mancini, Robert Alexander Hegele, Lawrence A. Leiter · 2013 · Canadian Journal of Diabetes
93. Predictive Value of Non-high-Density Lipoprotein Cholesterol and Neutrophil-Lymphocyte Ratio for Coronary Artery Vulnerable Plaques in Type 2 Diabetes Mellitus
    Xiyi Huang, Shaomin Yang, Qiang Zhao, Xinjie Chen, Jialing Pan, Shaofen Lai, Fusheng Ouyang, Lingda Deng, Yongxing Du, Xiaohong Li et al. · 2022 · Frontiers in Cardiovascular Medicine
94. Clinoptilolite for Treatment of Dyslipidemia: Preliminary Efficacy Study
    Milisav R. Cutovic, Milica P. Lazovic, Vesna Vuković-Dejanović, Dejan Nikolić, Ivana Petronić, Dragana Ćirović · 2017 · The Journal of Alternative and Complementary Medicine
95. Pemafibrate decreases triglycerides and small, dense LDL, but increases LDL-C depending on baseline triglycerides and LDL-C in type 2 diabetes patients with hypertriglyceridemia: an observational study
    Ichiro Komiya, Akira Yamamoto, Suguru Sunakawa, Tamio Wakugami · 2021 · Lipids in Health and Disease
96. Nonstatins and Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Inhibitors: Role in Non‐Familial Hypercholesterolemia
    Jennifer G. Robinson · 2016 · Progress in Cardiovascular Diseases
97. Pedoman Tatalaksana Dislipidemia PERKI 2013
    Erwinanto Erwinanto, Anwar Santoso, Johannes NE Putranto, Pradana Tedjasukmana, Rurus Suryawan, Sodiqur Rifqi, Sutomo Kasiman · 2015 · Indonesian Journal of Cardiology
98. Lipoprotein-associated phospholipase A2 mass and activity in children with heterozygous familial hypercholesterolemia and unaffected siblings: Effect of pravastatin
    Sung Kee Ryu, Barbara A. Hutten, Maud N. Vissers, Albert Wiegman, John J.P. Kastelein, Sotirios Tsimikas · 2010 · Journal of clinical lipidology
99. Lowering triglycerides to modify cardiovascular risk: will icosapent deliver?
    Stephen James Nicholls, Daniel J Scherer · 2015 · Vascular Health and Risk Management
100. Effect of dietary modification by calorie restriction on cholesterol levels in lipoprotein(a) and other lipoprotein classes
     Yuji Hirowatari, Daisuke Manita, Keiko Kamachi, Akira Tanaka · 2016 · Annals of Clinical Biochemistry International Journal of Laboratory Medicine